Sharechat Logo

Ebos Group Limited (NZX: EBO) Half Year Results

Wednesday 17th February 2021

Text too small?

EBOS Group Limited today announced another record result for the first half of the 2021 financial year, including double-digit NPAT growth.

In today’s results announcement, EBOS Chief Executive Officer, John Cullity said: “It is pleasing to report another record profit for EBOS for the first half of FY21. Our double-digit earnings growth reflects a continuation of the strong first quarter momentum that we announced at our Annual Meeting in October 2020.”

“Both our Healthcare and Animal Care segments recorded very strong growth and contributed to the overall result. This again reinforces the strength of our diverse portfolio of businesses.”

Key highlights of the first half included:

• Revenue of $4.7 billion (up 6.3%);

• Statutory Net Profit after Tax (NPAT) of $92.9 million (up 13.7%);

• Underlying Net Profit after Tax (Underlying NPAT) of $94.3 million (up 14.2%);

• Interim dividend declared of NZ 42.5 cents per share (up 13.3%);

• Very strong performances from both our Healthcare and Animal Care segments, with Healthcare’s Underlying EBIT up 11.2% and Animal Care’s EBIT up 25.6%;

• Excellent operating cash flow of $98.7 million (up 33.0%);

• Acquisition of CH2’s vet distribution business for approximately $9 million, which further strengthens Lyppard’s market position in this sector. This adds to the previously announced acquisition of Cryomed, which further expands our medical devices business; and

• Further strengthening of our balance sheet, with Net Debt : EBITDA reducing to 1.00x (1.11x at June 2020). Following further refinancing initiatives in August 2020 and February 2021, EBOS has no debt maturities until 2H FY23.

Interim Dividend

The Directors declared an interim dividend of NZ 42.5 cents per share, an increase of 13.3% on the prior corresponding period. This implies a dividend payout ratio of 69.0%, broadly consistent with recent periods.

Please see the links below for details:

Media Release

Investor Presentation

Half Year Financial Statements

ASX Appendix 4D

NZX Results Announcement

NZX Distribution Notice

Directors' declaration

Shareholders report

Source: Ebos Group Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

GSH Appointment of new Chairman
Greenfern secures agreement to supply medicinal cannabis
Rua on track to export to Germany by year end
HMY SECURES ADDITIONAL NZ$215M FACILITY TO SUPPORT GROWTH
Seeka releases Sustainability Report
NZL - Completion of Retail Offer
28th June 2022 Morning Report
Green Cross Health Limited 2022 Annual Report / NOM
Me Today completes Rights Issue
Channel confirms timing of Board Chair succession